Table 3.
Baseline clinical characteristics for PLH receiving ART care in Dar es Salaam, Tanzania
| Characteristics | Comparison | Intervention | p value1 |
|---|---|---|---|
| Mean CD4 (SD) | 270 (173.4) | 308 (184.1) | 0.76 |
| Immune suppression | |||
| Severe immunosuppression (CD4 < 200) | 116 (28.5) | 96 (23.1) | 0.09 |
| Moderate immune suppression (CD4 = 200 to <350) | 119 (29.2) | 138 (33.2) | |
| Not immune suppressed (CD4 ≥ 350) | 173 (42.4) | 182 (43.8) | |
| Mean hemoglobin (SD) | 10 (2.1) | 9 (1.9) | 0.09 |
| Low hemoglobin(anemia) mean (SD) | 11 (2.6) | 5 (1.2) | |
| Severe anemia (<8.5) | 60 (14.7) | 52 (12.5) | 0.03 |
| Moderate anemia (8.6 to <10) | 179 (43.9) | 278 (88.8) | |
| Mild anemia (10 to <12) | 122 (29.9) | 81 (19.5) | |
| No anemia (>12) | 44 (9.0) | 91 (22.0) | |
| Mean weight (kg) (SD) | 60 (11.9) | 61 (12.7) | 0.33 |
| Weight groups (kg) | 0.21 | ||
| <45 | 72 (18.6) | 21 (5.1) | |
| 45–60 | 88 (21.6) | 50 (12.0) | |
| >60 | 227 (55.6 | 341 (82.0) | |
| Mean duration on ART at baseline, mean (SD) | 18 (17.0) | 20 (16.0) | 0.23 |
N-intervention group = 412 and 367 control group: A total of 21 participants in the comparison group and 4 in the intervention had missing data and were omitted
1p-value was obtained from Chi Square test